Pharmaceutical Preparations · DE · CIK 873303
Sarepta Therapeutics develops and commercializes RNA-targeted therapies for rare genetic diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 12, 2026: 2 sold $417K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Mayo StephenDirector | Sell | 7,239 | $17.02 | $123K |
| Dec 16, 2025 | Estepan Ian MichaelChief Operating Officer | Sell | 13,187 | $22.31 | $294K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.